S. Karger AG

SHERPA: Unknown

People

  1. Bodei
    Bodei
  2. Chaft
    Chaft
  3. Devlin
    Devlin
  4. Janjigian
    Janjigian
  5. Landau
    Landau
  6. Mauro
    Mauro
  7. Motzer
    Motzer
  8. Rosenberg
    Rosenberg
  9. Tang
    Tang

Groups

  1. Department of Medicine (12)
  2. Sloan Kettering Institute Postdocs (11)
  3. Solid Tumor Oncology Division (8)
  4. Molecular Imaging and Therapy Service (7)
  5. Radiology, Department of (7)
  6. Center for Hematologic Malignancies (4)
  7. Hematologic Malignancies, Division of (4)
  8. Thoracic Oncology (4)
  9. Executive Committee, Center for Hematologic Malignancies (2)
  10. Gastrointestinal Oncology Service (2)
Search Within
  1. "2017"
Formats
  1. Meeting Abstract (19)
  2. Journal Article (6)
Groups
  1. Department of Medicine (12)
  2. Sloan Kettering Institute Postdocs (11)
  3. Solid Tumor Oncology Division (8)
  4. Molecular Imaging and Therapy Service (7)
  5. Radiology, Department of (7)
  6. Center for Hematologic Malignancies (4)

More Groups

People
  1. Lisa Bodei (7)
  2. Katja Pinker-Domenig (3)
  3. Matthew Hellmann (2)
  4. Anas Younes (1)
  5. Bob Li (1)
  6. Diane Reidy (1)

More People

Years
  1. 2017 (25)
Publications
  1. Neuroendocrinology (10)
  2. Oncology Research and Treatment (10)
  3. Breast Care (3)
  4. Human Heredity (1)
  5. Journal of Vascular Research (1)

Results (25)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Evaluation of nivolumab (nivo) alone and in combination with ipilimumab (ipi) in patients (pts) with advanced (adv) small-cell lung cancer (SCLC): First report of a randomized expansion cohort from the CheckMate 032 trial
    Meeting Abstract

    Atmaca, A.; Hellmann, M. D.; Ott, P. A.; Zugazagoitia, J.; Ready, N.; Hann, C. L.; De Braud, F.; Antonia, S.; Ascierto, P.; Moreno, V.; more...
    Oncology Research and Treatment (2017)

    Fulltext@MSK | Save
  • Atezolizumab as 1L therapy for advanced NSCLC in PD-L1-selected patients: Updated ORR, PFS and OS data from the BIRCH study
    Meeting Abstract

    Eberhardt, W. E. E.; Garassino, M. C.; Rizvi, N. A.; Jänne, P. A.; Christoph, D.; Peters, S.; Toh, C. K.; Kurata, T.; Costa, E. C.; Koczywas, M.; more...
    Oncology Research and Treatment (2017)

    Fulltext@MSK | Save
  • Tumor mutation burden (TMB) is associated with improved efficacy of atezolizumab in 1L and 2L+ NSCLC patients
    Meeting Abstract

    Griesinger, F.; Kowanetz, M.; Zou, W.; Shames, D. S.; Cummings, C. A.; Rizvi, N. A.; Spira, A.; Frampton, G.; Leveque, V.; Flynn, S.; more...
    Oncology Research and Treatment (2017)

    Fulltext@MSK | Save
  • Nivolumab for relapsed/refractory classical Hodgkin lymphoma after autologous transplantation: Full results after extended follow-up of the multicohort, multicenter phase 2 CheckMate 205 trial
    Meeting Abstract

    Jäger, U.; Engert, A.; Fanale, M.; Santoro, A.; Armand, P.; Ansell, S.; Zinzani, P. L.; Timmerman, J. M.; Collins, G. P.; Ramchandren, R.; more...
    Oncology Research and Treatment (2017)

    Fulltext@MSK | Save
  • NEOD001 demonstrates organ biomarker responses in patients with light chain amyloidosis and persistent organ dysfunction independently of previous hematologic response
    Meeting Abstract

    Liedtke, M.; Comenzo, R. L.; Landau, H.; Sanchorawala, V.; Weiss, B. M.; Zonder, J. A.; Schönland, S. O.; Walling, J.; Kinney, G. G.; Koller, M.; more...
    Oncology Research and Treatment (2017)

    Fulltext@MSK | Save
  • A phase II study of atezolizumab (atezo) with or without bevacizumab (bev) vs sunitinib (sun) in untreated metastatic renal cell carcinoma (mRCC) patients (pts)
    Meeting Abstract

    Grünwald, V.; McDermott, D. F.; Atkins, M.; Motzer, R.; Rini, B.; Escudier, B.; Fong, L.; Joseph, R.; Pal, S. K.; Sznol, M. M. D.; more...
    Oncology Research and Treatment (2017)

    Fulltext@MSK | Save
  • Bosutinib (BOS) vs imatinib (IM) for newly diagnosed chronic myeloid leukemia (CML): Initial results from the BFORE trial
    Meeting Abstract

    Brümmendorf, T. H.; Gambacorti-Passerini, C.; Deininger, M.; Mauro, M. J.; Chuah, C.; Kim, D. W.; Le Coutre, P.; Jentsch-Ullrich, K.; Waller, C.; Wolf, D.; more...
    Oncology Research and Treatment (2017)

    Fulltext@MSK | Save
  • Atezolizumab (atezo) in platinum-treated locally advanced or metastatic urothelial carcinoma (mUC): Outcomes by prior therapy
    Meeting Abstract

    v. Amsberg, G.; Perez-Garcia, J. L.; Loriot, Y.; Rosenberg, J. E.; Powles, T.; Necchi, A.; Hussain, S. A.; Morales-Barrera, R.; Retz, M.; Niegisch, G.; more...
    Oncology Research and Treatment (2017)

    Fulltext@MSK | Save
  • Application of BI-RADS descriptors in contrast-enhanced dual-energy mammography: Comparison with MRI
    Journal Article

    Knogler, T.; Homolka, P.; Hoernig, M.; Leithner, R.; Langs, G.; Waitzbauer, M.; Pinker, K.; Leitner, S.; Helbich, T. H.
    Breast Care (2017)

    Fulltext@MSK | Save
  • ENETS Consensus Guidelines for the standards of care in neuroendocrine neoplasms: Peptide receptor radionuclide therapy with radiolabelled somatostatin analogues
    Journal Article

    Hicks, R. J.; Kwekkeboom, D. J.; Krenning, E.; Bodei, L.; Grozinsky-Glasberg, S.; Arnold, R.; Borbath, I.; Cwikla, J.; Toumpanakis, C.; Kaltsas, G.; more...
    Neuroendocrinology (2017)

    Fulltext@MSK | Save